Shuhei Yoshida, Miroslaw Kornek, Naoki Ikenaga, Moritz Schmelzle, Ryota Masuzaki, Eva Csizmadia, Yan Wu, Simon C. Robson, Detlef Schuppan – 31 May 2013 – Radiofrequency ablation (RFA) is a potentially curative therapy for hepatocellular carcinoma (HCC). However, incomplete RFA can induce accelerated invasive growth at the periphery. The mechanisms underlying the RFA‐induced tumor promotion remain largely unexplored. Three human HCC cell lines were exposed to 45°C‐55°C for 10 minutes, simulating the marginal zone of RFA treatment.

Juan Acevedo, Javier Fernández, Verónica Prado, Anibal Silva, Miriam Castro, Marco Pavesi, Daria Roca, Wladimiro Jimenez, Pere Ginès, Vicente Arroyo – 31 May 2013 – The prevalence of relative adrenal insufficiency (RAI) in critically ill cirrhosis patients with severe sepsis is over 60% and associated features include poor liver function, renal failure, refractory shock, and high mortality. RAI may also develop in noncritically ill cirrhosis patients but its relationship to the clinical course has not yet been assessed.

Juan Acevedo, Javier Fernández, Verónica Prado, Anibal Silva, Miriam Castro, Marco Pavesi, Daria Roca, Wladimiro Jimenez, Pere Ginès, Vicente Arroyo – 31 May 2013 – The prevalence of relative adrenal insufficiency (RAI) in critically ill cirrhosis patients with severe sepsis is over 60% and associated features include poor liver function, renal failure, refractory shock, and high mortality. RAI may also develop in noncritically ill cirrhosis patients but its relationship to the clinical course has not yet been assessed.

Celien Vreuls, Eddie Wisse, Hans Duimel, Kris Stevens, Fons Verheyen, Filip Braet, Ann Driessen, Ger Koek – 31 May 2013

Luna Luo, Faustine Luo, Tony Wang – 31 May 2013

Shunji Nagai, Atsushi Yoshida, Keisuke Kohno, David Altshuler, Mio Nakamura, Kimberly A. Brown, Marwan S. Abouljoud, Dilip Moonka – 31 May 2013 – Lymphocytes play an active role in natural immunity against hepatitis C virus (HCV). We hypothesized that a lower absolute lymphocyte count (ALC) may alter HCV outcome after liver transplantation (LT). The aim of this study was to investigate the impact of peritransplant ALC on HCV recurrence following LT. A total of 289 LT patients between 2005 and 2011 were evaluated.

Shunji Nagai, Atsushi Yoshida, Keisuke Kohno, David Altshuler, Mio Nakamura, Kimberly A. Brown, Marwan S. Abouljoud, Dilip Moonka – 31 May 2013 – Lymphocytes play an active role in natural immunity against hepatitis C virus (HCV). We hypothesized that a lower absolute lymphocyte count (ALC) may alter HCV outcome after liver transplantation (LT). The aim of this study was to investigate the impact of peritransplant ALC on HCV recurrence following LT. A total of 289 LT patients between 2005 and 2011 were evaluated.

Julia Freimuth, Jörg‐Martin Bangen, Daniela Lambertz, Wei Hu, Yulia Alexandrowna Nevzorova, Roland Sonntag, Nikolaus Gassler, Dieter Riethmacher, Christian Trautwein, Christian Liedtke – 31 May 2013 – The cytokine tumor necrosis factor alpha (TNF‐α; TNF) plays a critical role early in liver regeneration following partial hepatectomy (PH). TNF stimulates at least three different pathways leading to nuclear factor kappa B (NF‐κB) activation, apoptosis signaling by way of caspase‐8 (Casp8), and activation of cJun N‐terminal kinases (JNK).

Pascal Lapierre, Kathie Béland, Fernando Alvarez – 31 May 2013

Wen‐Ping Xu, Min Yi, Qian‐Qian Li, Wei‐Ping Zhou, Wen‐Ming Cong, Yuan Yang, Bei‐Fang Ning, Chuan Yin, Zhao‐Wei Huang, Jian Wang, Hui Qian, Cai‐Feng Jiang, Yue‐Xiang Chen, Chun‐Yan Xia, Hong‐Yang Wang, Xin Zhang, Wei‐Fen Xie – 31 May 2013 – MicroRNA 370 (miR‐370) is located within the DLK1/DIO3 imprinting region on human chromosome 14, which has been identified as a cancer‐associated genomic region. However, the role of miR‐370 in malignances remains controversial. Here, we report that miR‐370 was repressed in human hepatocellular carcinoma (HCC) tissues and hepatoma cell lines.